Skip to main content

ADAP Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Adaptimmune Therapeutics plc News

Consolidated Edison, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer weighs in on Consolidated Edison, Clorox, Chesapeake Energy, Adaptimmune Therapeutics, Icahn Enterprises, Bristol-Meyers Squibb and more.

Where the Bears Are: Cramer's 'Mad Money' Recap (Tuesday 5/15/18)

Get ahead of the naysayers, says Jim Cramer. FANG and other tech leaders have gone cold, but they're not dead yet.

4 Strong Buy Biotech Stocks Poised to Explode

Here comes the growth. These four strong buy biotech stocks are potentially on the cusp of very big growth.

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Here's what you need to know now for Monday, Jan. 22.

Breaking News

Amazon Takes Small Stake in Meal Delivery Group Grubhub; Uber, DoorDash Stock Slide

"Amazon has redefined convenience with Prime and we're confident this offering will expose many new diners to the value of Grubhub+," said Grubhub CEO Adam DeWitt.

Tesla Sells Record 78,000 China-Made Cars In June Amid Production Rebound

Tesla sold a record 78,000 China-made cars last month, an industry group reported Wednesdsay.

Is Tesla Stock a Buy or Sell After Q2 Deliveries Report? Check the Chart.

Tesla's second-quarter deliveries climbed year over year but fell from the first quarter. Here's how to trade the stock now.